Respiratory

A novel lipid nanoparticle (LNP)-mRNA vaccine has demonstrated strong immune responses and enhanced protection against Mycobacterium tuberculosis, the leading cause of infectious mortality worldwide.

Pulmonary fibrosis (PF), a severe form of lung disease, often leads to irreversible lung damage, and macrophages play a critical role in its progression.

Clinical practice guidelines providing critical recommendations for managing central airway obstruction (CAO), a condition linked to poor prognosis in both malignant and nonmalignant airway diseases, have recently been published.

A new study explores the evolution of tuberculosis isolation, from early misconceptions to modern airborne transmission guidelines. See how TB control measures have changed.

A real-world study from the Netherlands has shared the benefits of lumacaftor/ivacaftor (lum/iva) in children with cystic fibrosis (CF) homozygous for the F508del mutation.

Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) may significantly reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with type 2 diabetes (T2D), according to a large U.S.-based study.

Five distinct long-term exposure profiles for the use of disinfectants and cleaning products (DCPs) and their potential association with asthma has been identified in new research.

The Los Angeles County wildfires in January 2025 had a notable impact on healthcare utilization, with emergency department (ED) visits decreasing by 9% while wildfire-associated visits spiked eightfold.